Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-12-03

FDA Approved: SILODOSIN — Original Application (Macleods Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Macleods Pharmaceuticals Limited's generic silodosin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silodosin (Silodosin)

Snippet

ORIG AP for SILODOSIN (SILODOSIN)